Nanoparticle Drug Delivery Platform

References

• Riley , S. 2006 . Innovation in drug delivery the future of nanotechnology and non‐invasive protein delivery . Healthcare; Business Insights Ltd. , : 25 – 26 .
   Google Scholar
• Duncan , R. 2003 . The dawning era of polymer therapeutics . Nature Reviews Drug Discovery , 2 : 347 – 360 .
   PubMed Web of Science ®Google Scholar
• Pison , U. W. , Giersig , M. and Groneberg , D. A. 2006 . Nanomedicine for Respiratory Diseases . European Journal of Pharmacology , 533 : 341 – 350 .
   PubMed Web of Science ®Google Scholar
• Barenholz , Y. 2001 . Liposome application: problems and prospects . Curr. Opin. Colloid Interface Sci. , 6 : 66 – 77 .
   Web of Science ®Google Scholar
• Lavasanifar , A. , Samuel , J. and Kwon , G. S. 2002 . Poly(ethylene oxide)‐block‐poly(L‐amino acid) micelles for drug delivery . Advanced Drug Delivery Reviews , 54 : 169 – 190 .
   PubMed Web of Science ®Google Scholar
• Torchilin , V. P. 2004 . Targeted polymeric micelles for delivery of poorly soluble drugs . Cell. Mol. Life Sci. , 61 : 2549 – 2559 .
   PubMed Web of Science ®Google Scholar
• Kwon , G. S. and Kataoka , K. 1995 . Block‐Copolymer Micelles as Long‐Circulating Drug Vehicles . Advanced Drug Delivery Reviews , 16 : 295 – 309 .
   Web of Science ®Google Scholar
• Pinto‐Alphandary , H. , Andremont , A. and Couvreur , P. 2000 . Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications . International Journal of Antimicrobial Agents , 13 ( 3 ) : 155 – 168 .
   PubMed Web of Science ®Google Scholar
• Drummond , D. C. , Meyer , O. , Hong , K. , Kirpotin , D. B. and Papahadjopoulos , D. 1999 . Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors . Pharmacological Reviews , 51 ( 4 ) : 691 – 743 .
   PubMed Web of Science ®Google Scholar
• Nishikawa , M. and Hashida , M. 2002 . Nonviral approaches satisfying various requirements for effective in vivo gene therapy . Biological & Pharmaceutical Bulletin , 25 ( 3 ) : 275 – 283 .
   Google Scholar
• Rao , M. and Alving , C. R. 2000 . Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen‐presenting cells . Advanced Drug Delivery Reviews , 41 ( 2 ) : 171 – 188 .
   PubMed Web of Science ®Google Scholar
• Wang , G. 2005 . “ Liposomes as drug delivery vehicles ” . In Drug Delivery Principles and Applications Edited by: Wang , B. , Siahaan , T. and Soltero , R. 411 – 434 . Hoboken : John Wiley and Sons .
   Google Scholar
• Allen , T. M. , Hansen , C. B. and Demenezes , D. E. L. 1995 . Pharmacokinetics of long‐circulating liposomes . Advanced Drug Delivery Reviews , 16 ( 2–3 ) : 267 – 284 .
   Google Scholar
• Gregoriadis , G. 1995 . Engineering liposomes for drug delivery: Progress and problems . Trends in Biotechnology , 13 ( 12 ) : 527 – 537 .
   PubMed Web of Science ®Google Scholar
• Torchilin , V. P. 1998 . Polymer‐coated long‐circulating microparticulate pharmaceuticals . Journal of Microencapsulation , 15 : 1 – 19 .
   PubMed Web of Science ®Google Scholar
• Park , Y. S. 2002 . Tumor‐directed targeting of liposomes . Bioscience Reports , 22 ( 2 ) : 267 – 281 .
   PubMed Web of Science ®Google Scholar
• Maruyama , K. 2002 . PEG‐immunoliposome . Bioscience Reports , 22 ( 2 ) : 251 – 266 .
   PubMed Web of Science ®Google Scholar
• Maruyama , K. , Ishida , O. , Takizawa , T. and Moribe , K. 1999 . Possibility of active targeting to tumor tissues with liposomes . Advanced Drug Delivery Reviews , 40 ( 1–2 ) : 89 – 102 .
   PubMed Web of Science ®Google Scholar
• Papahadjopoulos , D. , Kirpotin , D. B. , Park , J. W. , Hong , K. , Shao , Y. , Shalaby , K. , Colburn , G. and Benz , C. C. 1999 . Targeting of drugs to solid tumors using anti‐HER2 Immunoliposomes . Journal of Liposome Research , 8 ( 4 ) : 425 – 442 .
   Google Scholar
• Torchilin , V. P. 2005 . Recent Advances with Liposomes as Pharmaceutical Carriers . Nature Reviews , 4 : 145 – 160 .
   Web of Science ®Google Scholar
• Vicent , M. J. and Duncan , R. 2006 . Polymer conjugates: nanosized medicines for treating cancer . Trends in Biotechnology , 24 ( 1 ) : 39 – 47 .
   PubMed Web of Science ®Google Scholar
• Malik , N. , Evagorou , E. G. and Duncan , R. 1999 . Dendrimer‐platinate: a novel approach to cancer chemotherapy . Anti‐Cancer Drugs , 10 ( 8 ) : 767 – 776 .
   Google Scholar
• Lee , C. C. , MacKay , J. A. , Frechet , J. M. J. and Szoka , F. C. 2005 . Designing dendrimers for biological applications . Nature Biotechnology , 23 ( 12 ) : 1517 – 1526 .
   PubMed Web of Science ®Google Scholar
• Diwan , M. , Elamanchili , P. , Lane , H. , Gainer , A. and Samuel , J. 2004 . Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses . Journal of Drug Targeting , 11 ( 8–10 ) : 495 – 507 .
   Google Scholar
• Shen , H. , Ackerman , A. L. , Cody , V. , Goidini , A. , Hinson , E. R. , Cresswell , P. , Edelson , R. L. , Saltzman , W. M. and Hanlon , D. J. 2006 . Enhanced and prolonged cross‐presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles . Immunology , 117 ( 1 ) : 78 – 88 .
   PubMed Web of Science ®Google Scholar
• Langer , R. 2000 . Biomaterials in drug delivery and tissue engineering: One laboratory's Experience . Accounts of Chemical Research , 33 ( 2 ) : 94 – 101 .
   PubMed Web of Science ®Google Scholar
• Bogunia‐Kubik , K. and Sugisaka , M. 2002 . From molecular biology to nanotechnology and nanomedicine . Biosystems , 65 : 123 – 138 .
   PubMed Web of Science ®Google Scholar
• Galindo‐Rodriguez , S. A. , Alleman , E. , Hatem , F. and Doelker , E. 2005 . Polymeric nanoparticles for oral delivery of drugs and vaccines: A critical evaluation of in vivo studies . Critical Reviews in Therapeutic Drug Carrier Systems , 22 ( 5 ) : 419 – 463 .
   PubMed Web of Science ®Google Scholar
• Shenoy , D. , Little , S. , Langer , R. and Amiji , M. 2005 . Poly(ethylene oxide)‐modified poly(beta‐amino ester) nanoparticles as a pH‐sensitive system for tumor‐targeted delivery of hydrophobic drugs: Part 2. In vivo distribution and tumor localization studies . Pharmaceutical Research , 22 ( 12 ) : 2107 – 2114 .
   Google Scholar
• Ramanan , R. M. K. , Chellamuthu , P. , Tang , L. and Nguyen , K. T. 2006 . Development of a temperature‐sensitive composite hydrogel for drug delivery applications . Biotechnology Progress , 22 ( 1 ) : 118 – 125 .
   Google Scholar
• Fernandez , V. V. A. , Tepale , T. , Sanchez‐Diaz , J. C. , Mendizabal , E. , Puig , J. E. and Soltero , J. F. A. 2006 . Thermoresponsive nanostructured poly(Nisopropylacrylamide) hydrogels made via inverse microemulsion polymerization . Colloid and Polymer Science , 284 ( 4 ) : 387 – 395 .
   Web of Science ®Google Scholar
• Park , E. K. , Kim , S. Y. , Lee , S. B. and Lee , Y. M. 2005 . Folate‐conjugated methoxy poly(ethylene glycol)/poly(epsiloncaprolactone) amphiphilic block copolymeric micelles for tumor‐targeted drug delivery . Journal of Controlled Release , 109 ( 1–3 ) : 158 – 168 .
   PubMed Web of Science ®Google Scholar
• Fukumori , Y. and Ichikawa , H. 2006 . Nanoparticles for cancer therapy and diagnosis . Advanced Powder Technology , 17 ( 1 ) : 1 – 28 .
   Web of Science ®Google Scholar
• McAllister , K. , Sazani , P. , Adam , M. , Cho , M. J. , Rubinstein , M. , Samulski , R. J. and DeSimone , J. M. 2002 . Polymeric nanogels produced via inverse microemulsion polymerization as potential gene and antisense delivery agents . Journal of the American Chemical Society , 124 ( 51 ) : 15198 – 15207 .
   PubMed Web of Science ®Google Scholar
• Rolland , J. P. , Maynor , B. W. , Euliss , L. E. , Exner , A. E. , Denison , G. M. and DeSimone , L. M. 2005 . Direct fabrication and harvesting of monodisperse, shape‐specific nanobiomaterials . Journal of the American Chemical Society , 127 : 10096 – 10100 .
   PubMed Web of Science ®Google Scholar
• Eulis , L. , DuPont , J. , Gratton , S. and DeSimone , J. M. 2006 . Imparting size, shape, and composition control of materials for nanomedicine . Chem. Soc. Rev. , 35 : 1 – 11 .
   Google Scholar